Currency: USD
Period
Q1 FY2024 Earnings
--
0.00
-1.24
No Data
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
XORTX Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
May 17 12:51 ET
XORTX Therapeutics | 20-F: Registration statement / Annual report / Transition report
May 10 16:17 ET
Apr 4 12:57 ET
Nov 30, 2023 16:04 ET
Read more